Careers
Media
Contact
Exscalate Logo
Our Approach
What is Exscalate
Exscalate Platform
Partnerships
Solutions
Pipeline
Research
Insights
Publications
Success Stories
Partner With Us

Accelerating the future of drug discovery

At Exscalate we master biological complexity combining our knowledge of pharmacology, artificial intelligence (AI) and supercomputing to design better drugs faster.
Learn More

Latest News and Updates

Working in partnership with pioneering biopharma start-ups and through collaborations with ambitious European projects, Exscalate’s AI-driven supercomputing platform is accelerating drug discovery with some very promising outcomes.
Large-Scale Inference of Molecular Polypharmacology: The New ProfhEX Platform for Bioactivity Estimation and Liability Assessment
13th February 2026
ProfhEX is a large-scale, ML-powered platform that predicts bioactivity across nearly 700 human targets, enabling early identification of off-target risks, polypharmacology profiles, and drug repurposing opportunities to support safer, more effective drug discovery
GENEOnet: Artificial Intelligence Unveils the Key to Protein Binding Sites
10th December 2025
Accelerating Drug Discovery with Smart, Accessible Technology
Drug Repurposing: When Data Unlocks New Therapeutic Opportunities
5th December 2025
A journey through the latest in silico advances and the hands-on experience of the European REMEDi4ALL project, showing how digital technologies are reshaping the future of drug development.

Partnerships

We have formed many successful partnerships. Together we are accelerating drug discovery.